Printer FriendlyPrintable version     Email this pageEmail this page
 
Search
 
 
  Advanced Search
 
Partnering
  Partnering Home
  Tech Transfer Offices
  Licensing Information
  Available Technologies
  Technologies by Subject
  Partnering Opportunities
  Agreements (CRADAs)
  Generic Forms
  Technology Successes
  Featured Item
  Legislative Affairs
  Vendors
 
 
  Display category headings
Partnering
Partnering >
Single-Site Amplification (SSA): Method for Accelerated Development of Nucleic Acid Markers
See also: US Patent Office Full Record

BT Patent Number: 6054300
Docket Number: 11597
Serial Number: 8915609
Date Patented: 04/25/2000

Technology Description:

The invention relates to a method for obtaining targeted DNA in less time with greater efficiency byeliminating genomic DNA library preparation and screening. This method reduces target DNA productionfrom months to days. The targeted DNA sequence prepared by this method can be used as a template foramplification procedures such as PCR, or can be employed as a molecular marker. Examples of target DNA forwhich this method will apply include simple sequence repeats (SSRs), footprints remaining from retroviralexcision, transposable elements, or any DNA element of a length that is too short to be identified and/orisolated by conventional PCR. The method uses a polymerase having strand displacement capability, oneprimer, and a circular DNA template.

Companies engaged in the manufacture of biological markers and diagnostic kits would be interested in the technology.  Biotechnology companies would also benefit from the technology.

Reference:

Please refer to USPN 6,054,300 (Docket #0115.97), which issued April 25, 2000.  Foreign rights are available.

Inventor:

William L. McKendree
Horticultural Research Laboratory
2199 S. Rock Road
Fort Pierce, Florida 34945
(561) 462-5943


 
ARS Home |  USDA |  Home | About Us | Research | Products & Services | People & Places  | News & Events | Partnering | Careers | Contact Us | Help |
Site Map |  Freedom of Information Act |  Statements & Disclaimers |  Employee Resources |  FirstGov |  White House